Details for Patent: 9,919,025

Which drugs does patent 9,919,025 protect, and when does it expire?

Patent 9,919,025 protects NOCDURNA and is included in one NDA.

This patent has forty-three patent family members in twenty-nine countries.

Summary for Patent: 9,919,025

Title:	Pharmaceutical formulations of desmopressin
Abstract:	Described herein are orodispersible pharmaceutical dosage forms of desmopressin comprising desmopressin free base or a pharmaceutically acceptable salt thereof, and one or more carriers, wherein at least one carrier is hydrolyzed gelatin in an open matrix network structure. Also described are methods of making and using such desmopressin orodispersible pharmaceutical dosage forms.
Inventor(s):	Nilsson; Anders (Lund, SE), Lindner; Hans (Berlin, DE), Wittendorff; Jorgen (Hvidovre, DK)
Assignee:	FERRING B.V. (Hoofddorp, NL)
Application Number:	15/333,503
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,919,025

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ferring Pharms Inc	NOCDURNA	desmopressin acetate	TABLET;SUBLINGUAL	022517-001	Jun 21, 2018		RX	Yes	No						TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS
Ferring Pharms Inc	NOCDURNA	desmopressin acetate	TABLET;SUBLINGUAL	022517-002	Jun 21, 2018		RX	Yes	Yes						TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS

Foreign Priority and PCT Information for Patent: 9,919,025

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0210397.6	May 7, 2002
	PCT/IB2002/004036	Sep 20, 2002

International Family Members for US Patent 9,919,025

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	039092
Argentina	039794
Argentina	107948
Austria	333886
Australia	2002337419
Australia	2003233118